Glenbrook Capital Management, which maintains a ten percent ownership position in SenesTech, Inc. (NASDAQ: SNES), has executed a recent acquisition of the company's common stock. The transaction details were formally disclosed in a Form 4 filing submitted to the Securities and Exchange Commission on June 22, 2026. The filing indicates that the activity occurred on June 17 and June 22, 2026.
According to the filing, Glenbrook Capital Management purchased a total of 8,264 shares of SenesTech common stock. These purchases were executed across two separate transactions. The acquisition prices for these shares ranged from $1.6139 to $1.6591 per share. The filing notes that these shares are held indirectly through an account for which Glenbrook Capital Management acts as the investment manager. As stated in the disclosure, Glenbrook Capital Management disclaims beneficial ownership of these securities for the purposes of Section 16, except to the extent of its pecuniary interest. Following this acquisition, the firm's indirect holdings in SenesTech common stock increased to a total of 962,408 shares.
This insider purchase activity is occurring while SNES stock is trading at $1.71. Over the past year, the stock has declined by 55.7%. Analysis from InvestingPro suggests that the stock may be undervalued at its current levels, with a Fair Value estimate indicating potential for upside. The company's balance sheet shows that it holds more cash than debt. However, InvestingPro Tips note that the company is burning through cash at a rapid pace. This assessment is part of a broader analysis available on the most undervalued stocks platform, which includes two additional tips for subscribers.
In recent operational developments, SenesTech reported a 2% increase in revenue for the first quarter of 2026. Revenue reached $493,000, compared to $485,000 in the same period last year. The company also achieved a record gross margin of 68.6%, an improvement from 64.5% in the first quarter of 2025. Additionally, SenesTech announced a distribution agreement with Animal and Garden House. This partnership aims to introduce its Evolve Rodent Birth Control products to the Bermuda market. This expansion is driven by regulatory restrictions on traditional rodenticides in Bermuda due to environmental concerns.
On the corporate governance front, SenesTech’s Board of Directors has amended a proposal to increase shares available under the company’s 2018 Equity Incentive Plan. The requested amount was reduced from 1.7 million shares to 1.2 million shares. This revised proposal will be presented to stockholders for approval at the company’s annual meeting in June 2026. These developments highlight the company's strategic moves in product distribution and corporate governance.